The shares of Coca-Cola European Partners Plc (NYSE:CCE) started off the last trading session with the price of $41.1 while closing the day with the price of $40.9. The shares of Coca-Cola European Partners Plc (NYSE:CCE) Fell -0.41% with the Loss of -0.2 points.
The shares of Coca-Cola European Partners Plc (NYSE:CCE) traded with the day volume of 1.56 Million shares whereas its average trading volume is 1.57 Million.
While analyzing the past performance of the stock we can see that the shares of Coca-Cola European Partners Plc (NYSE:CCE) Gain 6.57% in the last week while rising 7.21% in the last month. Past quarter performance shows the green light with 3.44%. The semi-annual and annual performance shows -4.99% and 15.67% respectively.
Some critical values of the shares of Coca-Cola European Partners Plc (NYSE:CCE) to be discussed here are: the beta which shows the value at 0.85 while Average True Range of Coca-Cola European Partners Plc (NYSE:CCE) demonstrate the value at 0.81. The weekly and monthly volatility of the shares of Coca-Cola European Partners Plc (NYSE:CCE) are indicated at 1.97% and 1.97%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 65.08.
While studying the financial position of the shares of Coca-Cola European Partners Plc (NYSE:CCE), we can see that the Market capitalization of the company is at 19.92 Billion. The shares outstanding for the company is 486.94 Million and the shares float stands at 216.04 Million. The income of the company stand at 1.24 Billion while the sales stand at 13.62 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.54, Price to Earnings or P/E is at 16.12, Price to Sales P/S show the value of 1.46, the Return on Asset ROA stood at 0.037 and the Return on Equity ROE depicted at 0.104 while Return on Investment ROI is at 0.089.
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) started its previous trading session at $25.98 and closed at $27.69 showing a Rise of 6.79 Percent.
The Company traded with an average Volume of 1.06 Million whereas, its Day Volume stood at 1.56 Million.
Looking at the performance of the stock, Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Gain 13.62% in the last week in its shares price and -24.12% in the last month. Quarterly performance shows a red of -19.81 Percent while Semi-Annual and Annual performances shows a 30.24 and 61.46 percent respectively.
Beta for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) stands at 1.58 while the ATR (average true range) is at 2.18. The Stock’s Weekly and Monthly Volatility is 5.95% and 7.93% respectively showing a RSI value of 44.76.
While studying the financial position of the shares of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), we can see that the Market capitalization of the company is at 666.78 Million. The shares outstanding for the company is 24.08 Million and the shares float stands at 24.08 Million.
The Company generated an income of -114400000 and the sales of 600000 in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-5.04 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 1111.29 respectively.
The Return on Assets stands at -0.595, ROE shows a value of -0.953 and ROI for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) is -0.659 as of Trailing Twelve Months period.
